HomeAI · summaries
Storia in 4 fonti
Patient dies in China biotech company’s gene editing trial
A patient with Duchenne muscular dystrophy died after receiving a gene-editing therapy in China, sparking new concerns about regulatory oversight and transparency as China seeks to cement its position as a biotechnology leader.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
statnews.com
Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
With a second delayed report of a child's death in China, criticism is rising of a looser form of clinical trial. One expert: what "bothers me is the lack of transparency.'
- ·
abc.es
Muere un segundo niño tratado en China con una terapia de edición genética
El paciente participaba en un ensayo clínico con una terapia experimental para corregir la distrofia muscular de Duchenne
